PM54

DRUG3 trials

Sponsors

Pharma Mar S.A., PharmaMar

Conditions

Advanced MalignanciesAdvanced Solid TumorAdvanced malignancies

Phase 1

Clinical Trial of PM54 in Advanced Solid Tumors Patients.

RecruitingNCT05841563

PharmaMarAdvanced Solid Tumor

Start: 2023-04-28End: 2027-04-30Target: 125Updated: 2025-09-24

A Multicenter, Open-label, Phase 1/2 Safety Run-in and Expansion Study of PM54 in Combination With Immunotherapy Evaluating Safety and Efficacy in Adult Participants who were Previously Treated for Advanced Malignancies

Not yet recruitingCTIS2025-523774-16-00

Pharma Mar S.A.Advanced malignancies

Target: 36Updated: 2026-04-24

Study of PM54 in Combination With Immunotherapy in Adult Participants With Advanced Malignancies

RecruitingNCT07644039

PharmaMarAdvanced Malignancies

Start: 2026-05-21End: 2029-04-02Target: 119Updated: 2026-07-30